October 13, 2016 / 10:01 AM / 9 months ago

BRIEF-Merck KGaA says still plan to apply for avelumab approval this year

1 Min Read

Oct 13 (Reuters) - Merck KGaA

* Says still plan to apply for marketing authorization in Europe, U.S. for avelumab against merkel cell carcinoma this year - CEO in media call Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below